DrugNov 1, 2017
Fluocinonide Gel USP, 0.05%, 15 g tube recall — FDA D-0146-2018
Cross contamination with other products: traces of Dapsone were found in the finished product.
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
Recall history in this database
Classification mix: Class II: 21, Class III: 10, Class I: 3.
DrugMay 24, 2017
Fluocinonide Cream UPS, 0.05% (Emulsified Base) recall — FDA D-0790-2017
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugApr 26, 2017
Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg recall — FDA D-0676-2017
Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 16, 2016
Taro Pharmaceuticals U.S.A Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE recall — FDA D-0134-2017
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugJun 8, 2016
Taro Pharmaceuticals U.S.A ¿Topicort (desoximetasone) Cream USP, 0.05% recall — FDA D-0950-2016
Subpotent Drug
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugFeb 11, 2015
Taro Pharmaceuticals U.S.A Children's Loratadine Syrup (Loratadine Oral Solution) 5 mg/5 mL recall — FDA D-0383-2015
Presence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugNov 5, 2014
Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle recall — FDA D-0049-2015
Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system. An alternate manufacturing…
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugSep 24, 2014
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles recall — FDA D-1584-2014
Failed Content Uniformity Specifications.
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugDec 18, 2013
Ciclopirox Shampoo 1%, Net Wt. 120 mL. bottles recall — FDA D-347-2014
Subpotent. drug
Class IIIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
DrugDec 12, 2012
Fluorouracil Topical Cream USP, 5%, 40 g Tube recall — FDA D-086-2013
Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Class IIFDA: TerminatedTaro Pharmaceuticals U.S.A., Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Taro Pharmaceuticals U.S.A., Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.